Jenoptik strengthens global photonics business with the acquisition of Berliner Glas Medical and SwissOptic
JENOPTIK AG (FSE: JEN / ISIN: DE000A2NB601) is set to acquire from Berliner Glas GmbH, a wholly-owned subsidiary of ASML Holding N.V., a 100 percent stake in BG Medical Applications GmbH (”Berliner Glas Medical“), a supplier of high-precision, custom optical components for the medical technology sector based in Berlin, as well as SwissOptic AG, a specialist in the development and manufacture of optical components and assemblies, primarily for the medical technology, semiconductor, and metrology industries headquartered in Heerbrugg/Switzerland, and the Chinese company SwissOptic (Wuhan) Co., Ltd., based in Wuhan/China.
The purchase price amounts to around 300 million euros. In 2022, the acquired companies are expected to contribute approximately 130 million euros in revenue. In the coming years, a revenue growth rate in the low double-digit percentage range with an attractive margin profile is expected.
The acquisition has already been approved by the JENOPTIK AG Supervisory Board, and is subject to the approval from the German Federal Cartel Office (Bundeskartellamt). Closing is expected for December 2021.